PMCID string | Sentences string | ner list |
|---|---|---|
PMC9429973 | Aims: The aim of this study is to identify drugs that are able to upregulate CD20 in BCP-ALL, in order to improve the efficacy of anti-CD20 mAbs in preclinical models of the disease. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Aims",
":",
"The",
"aim",
"of",
"this",
"study",
"is",
"to",
"identify",
"drugs",
"that",
"are",
"able",
"to",
"upregulate",
"CD20",
"in",
"BCP-ALL",
",",
"in",
"order",
"to",
"improve",
"the",
"efficacy",
"of",
"anti-CD20",
"mAbs",
"in",
"preclinical",
"models",
"of",
"the",
"disease",
"."
]
}
] |
PMC9220170 | A-172 cells were loaded with the probe dissolved in Hanks balanced salt solution (HBSS) composed of (mM): 156 NaCl, 3 KCl, 2 MgSO4, 1.25 KH2PO4, 2 CaCl2, 10 glucose, and 10 HEPES, pH 7.4 at 37 °C for 40 min with subsequent 15 min washout. | [
{
"tags": [
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A-172",
"cells",
"were",
"loaded",
"with",
"the",
"probe",
"dissolved",
"in",
"Hanks",
"balanced",
"salt",
"solution",
"(",
"HBSS",
")",
"composed",
"of",
"(",
"mM",
"):",
"156",
"NaCl",
",",
"3",
"KCl",
",",
"2",
"MgSO4",
",",
"1.25",
"KH2PO4",
",",
"2",
"CaCl2",
",",
"10",
"glucose",
",",
"and",
"10",
"HEPES",
",",
"pH",
"7.4",
"at",
"37",
"°",
"C",
"for",
"40",
"min",
"with",
"subsequent",
"15",
"min",
"washout",
"."
]
}
] |
PMC11711347 | Given that the raw materials used in the synthesis of the complex are considered safe for biological systems, it is anticipated that the Ni(II)cysteine-tyrosinedithiocarbamate complex will have minimal adverse effects on normal cells . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Given",
"that",
"the",
"raw",
"materials",
"used",
"in",
"the",
"synthesis",
"of",
"the",
"complex",
"are",
"considered",
"safe",
"for",
"biological",
"systems",
",",
"it",
"is",
"anticipated",
"that",
"the",
"Ni(II)cysteine-tyrosinedithiocarbamate",
"complex",
"will",
"have",
"minimal",
"adverse",
"effects",
"on",
"normal",
"cells",
"."
]
}
] |
PMC11001582 | Knock-in constructs were obtained by inserting sequences from pMC-eGFP, pMC-(GR)400 and pMC-(PR)400 into targeting vectors within the BstXI and XcmI sites. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Knock-in",
"constructs",
"were",
"obtained",
"by",
"inserting",
"sequences",
"from",
"pMC-eGFP",
",",
"pMC-(GR)400",
"and",
"pMC-(PR)400",
"into",
"targeting",
"vectors",
"within",
"the",
"BstXI",
"and",
"XcmI",
"sites",
"."
]
}
] |
PMC11225860 | Fig. 4Alisertib treatment causes cell cycle disruption and endomitosis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Fig.",
"4Alisertib",
"treatment",
"causes",
"cell",
"cycle",
"disruption",
"and",
"endomitosis",
"."
]
}
] |
PMC9429973 | Four studies included patients with α-thal but did not report HRQoL results separately for this subgroup. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Four",
"studies",
"included",
"patients",
"with",
"α-thal",
"but",
"did",
"not",
"report",
"HRQoL",
"results",
"separately",
"for",
"this",
"subgroup",
"."
]
}
] |
PMC9429973 | Methods: Here, we integrated the differential gene expression profile between SOX11+ and SOX11- MCL primary cases with stem cell-related genes, specific SOX11 ChIP-chip bound genes and epigenomic data of MCLs. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Methods",
":",
"Here",
",",
"we",
"integrated",
"the",
"differential",
"gene",
"expression",
"profile",
"between",
"SOX11",
"+",
"and",
"SOX11-",
"MCL",
"primary",
"cases",
"with",
"stem",
"cell-related",
"genes",
",",
"specific",
"SOX11",
"ChIP-chip",
"bound",
"genes",
"and",
"epigenomic",
"data",
"of",
"MCLs",
"."
]
}
] |
PMC11409031 | Consequently, additional confirmation is required for the clinical prognostic model developed in this research, particularly through larger sample size cohorts and additional clinical data. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Consequently",
",",
"additional",
"confirmation",
"is",
"required",
"for",
"the",
"clinical",
"prognostic",
"model",
"developed",
"in",
"this",
"research",
",",
"particularly",
"through",
"larger",
"sample",
"size",
"cohorts",
"and",
"additional",
"clinical",
"data",
"."
]
}
] |
PMC11637716 | A female child of non‐consanguineous parents was born preterm after 35 + 3/7 gestational weeks in an external hospital. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"female",
"child",
"of",
"non‐consanguineous",
"parents",
"was",
"born",
"preterm",
"after",
"35",
"+",
"3/7",
"gestational",
"weeks",
"in",
"an",
"external",
"hospital",
"."
]
}
] |
PMC9429973 | Aims: The purpose of this study is to describe the indications and the modalities of radiotherapy (RT) for patients with RR-HL in our center, as well as its therapeutic results. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Aims",
":",
"The",
"purpose",
"of",
"this",
"study",
"is",
"to",
"describe",
"the",
"indications",
"and",
"the",
"modalities",
"of",
"radiotherapy",
"(",
"RT",
")",
"for",
"patients",
"with",
"RR-HL",
"in",
"our",
"center",
",",
"as",
"well",
"as",
"its",
"therapeutic",
"results",
"."
]
}
] |
PMC3730428 | Thus, by ubiquitinating RIPK1, cIAP1 and cIAP2 act as positive regulators of the generally antiapoptotic, pro-inflammatory canonical NF-κB signaling pathway and at the same time inhibit caspase 8 activation in response to ligation of TNFR1. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Thus",
",",
"by",
"ubiquitinating",
"RIPK1",
",",
"cIAP1",
"and",
"cIAP2",
"act",
"as",
"positive",
"regulators",
"of",
"the",
"generally",
"antiapoptotic",
",",
"pro-inflammatory",
"canonical",
"NF-κB",
"signaling",
"pathway",
"and",
"at",
"the",
"same",
"time",
"inhibit",
"caspase",
"8",
"activation",
"in",
"response",
"to",
"ligation",
"of",
"TNFR1",
"."
]
}
] |
PMC10454535 | Of the treatment groups, PIN showed the greatest expression of these proteins while the PIN/BTZ combination showed the least expression. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Of",
"the",
"treatment",
"groups",
",",
"PIN",
"showed",
"the",
"greatest",
"expression",
"of",
"these",
"proteins",
"while",
"the",
"PIN/BTZ",
"combination",
"showed",
"the",
"least",
"expression",
"."
]
}
] |
PMC11144382 | One gene, cellular retinoic acid binding protein 2 (Crabp2), was upregulated at both the RNA (2.59 fold, Table S2) and protein (2.83 fold, Table S2) levels, while 4 genes, vascular cell adhesion molecule 1 (Vcam1), potassium channel tetramerization domain containing 12 (Kctd12), isopentenyl-diphosphate delta isomerase 1 (Idi1), and eukaryotic translation initiation factor 2 subunit 3 structural gene Y-linked (Eif2s3y), were downregulated at both the RNA (-2.23 fold, -3.53 fold, -5.90 fold, and -7305.15 fold, respectively, Table S2) and protein (-4.89 fold, -4.77 fold, -2.14 fold, and -5.28 fold, respectively, Table S2) levels. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"One",
"gene",
",",
"cellular",
"retinoic",
"acid",
"binding",
"protein",
"2",
"(",
"Crabp2",
")",
",",
"was",
"upregulated",
"at",
"both",
"the",
"RNA",
"(",
"2.59",
"fold",
",",
"Table",
"S2",
")",
"and",
"protein",
"(",
"2.83",
"fold",
",",
"Table",
"S2",
")",
"levels",
",",
"while",
"4",
"genes",
",",
"vascular",
"cell",
"adhesion",
"molecule",
"1",
"(",
"Vcam1",
")",
",",
"potassium",
"channel",
"tetramerization",
"domain",
"containing",
"12",
"(",
"Kctd12",
")",
",",
"isopentenyl-diphosphate",
"delta",
"isomerase",
"1",
"(",
"Idi1",
")",
",",
"and",
"eukaryotic",
"translation",
"initiation",
"factor",
"2",
"subunit",
"3",
"structural",
"gene",
"Y-linked",
"(",
"Eif2s3y",
")",
",",
"were",
"downregulated",
"at",
"both",
"the",
"RNA",
"(",
"-2.23",
"fold",
",",
"-3.53",
"fold",
",",
"-5.90",
"fold",
",",
"and",
"-7305.15",
"fold",
",",
"respectively",
",",
"Table",
"S2",
")",
"and",
"protein",
"(",
"-4.89",
"fold",
",",
"-4.77",
"fold",
",",
"-2.14",
"fold",
",",
"and",
"-5.28",
"fold",
",",
"respectively",
",",
"Table",
"S2",
")",
"levels",
"."
]
}
] |
PMC9429973 | In the course of our work, we propose to screen for cases of anemia in patients with deep vein thrombosis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"the",
"course",
"of",
"our",
"work",
",",
"we",
"propose",
"to",
"screen",
"for",
"cases",
"of",
"anemia",
"in",
"patients",
"with",
"deep",
"vein",
"thrombosis",
"."
]
}
] |
PMC11740508 | A–D p-H2A.X foci per nucleus in the M231 variants and in SUM149PT quantitated over 4 days. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"–",
"D",
"p-H2A.X",
"foci",
"per",
"nucleus",
"in",
"the",
"M231",
"variants",
"and",
"in",
"SUM149PT",
"quantitated",
"over",
"4",
"days",
"."
]
}
] |
PMC6617630 | Our study also demonstrated that CD47 is expressed on the DHL and THL cells and abrogated by JQ1 treatment. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Our",
"study",
"also",
"demonstrated",
"that",
"CD47",
"is",
"expressed",
"on",
"the",
"DHL",
"and",
"THL",
"cells",
"and",
"abrogated",
"by",
"JQ1",
"treatment",
"."
]
}
] |
PMC11766174 | Supernatant obtained from the cell culture was centrifuged at 10,000× g for 5 min at RT to remove insoluble material before measuring CA levels on the Quanterix analyzer (Quanterix, Bullerica, MA, USA). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Supernatant",
"obtained",
"from",
"the",
"cell",
"culture",
"was",
"centrifuged",
"at",
"10,000",
"×",
"g",
"for",
"5",
"min",
"at",
"RT",
"to",
"remove",
"insoluble",
"material",
"before",
"measuring",
"CA",
"levels",
"on",
"the",
"Quanterix",
"analyzer",
"(",
"Quanterix",
",",
"Bullerica",
",",
"MA",
",",
"USA",
")",
"."
]
}
] |
PMC11306331 | For dark-incubated cells we observed a sharp threshold in cellular FUS expression above which nuclear condensates were observed and corresponded to high enrichment scores (maximum divided by mean nuclear pixel intensity) (Fig. 3A, purple dots). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"dark-incubated",
"cells",
"we",
"observed",
"a",
"sharp",
"threshold",
"in",
"cellular",
"FUS",
"expression",
"above",
"which",
"nuclear",
"condensates",
"were",
"observed",
"and",
"corresponded",
"to",
"high",
"enrichment",
"scores",
"(",
"maximum",
"divided",
"by",
"mean",
"nuclear",
"pixel",
"intensity",
")",
"(",
"Fig.",
"3A",
",",
"purple",
"dots",
")",
"."
]
}
] |
PMC7039683 | Peaks were called using MACS2 (v2.1.1) (Zhang et al., 2008). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Peaks",
"were",
"called",
"using",
"MACS2",
"(",
"v2.1.1",
")",
"(",
"Zhang",
"et",
"al.",
",",
"2008",
")",
"."
]
}
] |
PMC11401358 | CD characterization of SF. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"CD",
"characterization",
"of",
"SF",
"."
]
}
] |
PMC11627133 | Evaluating the fluorescence turn‐on and affinity of AP3‐SiRA connected via Loop1 (UGAA) or via Loop2 (UUCG) with the fluorogenic silicon rhodamine (SiR) dye revealed that only fusion into Loop2 retained SiRA's binding and turn‐on (Figure S6A, C, I). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Evaluating",
"the",
"fluorescence",
"turn‐on",
"and",
"affinity",
"of",
"AP3‐SiRA",
"connected",
"via",
"Loop1",
"(",
"UGAA",
")",
"or",
"via",
"Loop2",
"(",
"UUCG",
")",
"with",
"the",
"fluorogenic",
"silicon",
"rhodamine",
"(",
"SiR",
")",
"dye",
"revealed",
"that",
"only",
"fusion",
"into",
"Loop2",
"retained",
"SiRA",
"'s",
"binding",
"and",
"turn‐on",
"(",
"Figure",
"S6A",
",",
"C",
",",
"I",
")",
"."
]
}
] |
PMC8956657 | The equivalent sequence in MERS-CoV ORF4b, RKRSHSP, lacks two Arg residues. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"equivalent",
"sequence",
"in",
"MERS-CoV",
"ORF4b",
",",
"RKRSHSP",
",",
"lacks",
"two",
"Arg",
"residues",
"."
]
}
] |
PMC6889484 | Severely delayed kinetics were observed in the 20% CEMSS:80% CEMSS/D128K clone mix 28 days post-infection (bottom). ( | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Severely",
"delayed",
"kinetics",
"were",
"observed",
"in",
"the",
"20",
"%",
"CEMSS:80",
"%",
"CEMSS/D128",
"K",
"clone",
"mix",
"28",
"days",
"post-infection",
"(",
"bottom",
")",
".",
"("
]
}
] |
PMC3765139 | Bonnet and colleagues were the first who could phenotypically distinguish cells of acute myeloid leukemia (AML) with high tumorigenicity from the remaining tumor cells using surface markers. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Bonnet",
"and",
"colleagues",
"were",
"the",
"first",
"who",
"could",
"phenotypically",
"distinguish",
"cells",
"of",
"acute",
"myeloid",
"leukemia",
"(",
"AML",
")",
"with",
"high",
"tumorigenicity",
"from",
"the",
"remaining",
"tumor",
"cells",
"using",
"surface",
"markers",
"."
]
}
] |
PMC11519567 | We used PRT4165 (TargetMol T3110) to block the H2AK119ub modification. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"used",
"PRT4165",
"(",
"TargetMol",
"T3110",
")",
"to",
"block",
"the",
"H2AK119ub",
"modification",
"."
]
}
] |
PMC9872547 | DMEM growth medium containing 10% (v: v) fetal bovine serum (FBS) and 1% (v: v) of penicillin and streptomycin (all from GibcoBioCult, Paisley, Scotland, UK) was used for the culture of HeLa and fibroblast cells. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O"
],
"tokens": [
"DMEM",
"growth",
"medium",
"containing",
"10",
"%",
"(",
"v",
":",
"v",
")",
"fetal",
"bovine",
"serum",
"(",
"FBS",
")",
"and",
"1",
"%",
"(",
"v",
":",
"v",
")",
"of",
"penicillin",
"and",
"streptomycin",
"(",
"all",
"from",
"GibcoBioCult",
",",
"Paisley",
",",
"Scotland",
",",
"UK",
")",
"was",
"used",
"for",
"the",
"culture",
"of",
"HeLa",
"and",
"fibroblast",
"cells",
"."
]
}
] |
PMC7823217 | Fig. 5Bioprinted ovarian cancer model: A. The major subtype of ovarian neoplasm histologically divided in two subclassifications: Type I ovarian cancer contains low-grade, slow developing neoplastic cells that genuinely comes from boarder line tumors, which itself arises from ovarian surface epithelium, cysts, or endometriosis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Fig.",
"5Bioprinted",
"ovarian",
"cancer",
"model",
":",
"A.",
"The",
"major",
"subtype",
"of",
"ovarian",
"neoplasm",
"histologically",
"divided",
"in",
"two",
"subclassifications",
":",
"Type",
"I",
"ovarian",
"cancer",
"contains",
"low-grade",
",",
"slow",
"developing",
"neoplastic",
"cells",
"that",
"genuinely",
"comes",
"from",
"boarder",
"line",
"tumors",
",",
"which",
"itself",
"arises",
"from",
"ovarian",
"surface",
"epithelium",
",",
"cysts",
",",
"or",
"endometriosis",
"."
]
}
] |
PMC11286266 | Transfected cells were selected in the presence of puromycin (8 μg/ml) and analysed under basal conditions at 7-, 19-, or 22-day post-transfection. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Transfected",
"cells",
"were",
"selected",
"in",
"the",
"presence",
"of",
"puromycin",
"(",
"8",
"μg/ml",
")",
"and",
"analysed",
"under",
"basal",
"conditions",
"at",
"7-",
",",
"19-",
",",
"or",
"22-day",
"post-transfection",
"."
]
}
] |
PMC11632064 | This suggests that the anti-inflammatory effects of BI-D1870 in A-375 cells (Fig 1D) are linked to RSK inhibition, as observed with selective RSK inhibitors such as LJH685 and LJI308 (Fig 1D and H). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"suggests",
"that",
"the",
"anti-inflammatory",
"effects",
"of",
"BI-D1870",
"in",
"A-375",
"cells",
"(",
"Fig",
"1D",
")",
"are",
"linked",
"to",
"RSK",
"inhibition",
",",
"as",
"observed",
"with",
"selective",
"RSK",
"inhibitors",
"such",
"as",
"LJH685",
"and",
"LJI308",
"(",
"Fig",
"1D",
"and",
"H",
")",
"."
]
}
] |
PMC9261184 | BOG consumption in this study was 88 kg/km (47.5 kg/Nm) and diesel consumption was 1.3 kg/km (0.7 kg/Nm), allowing for all uses of gas and diesel. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"BOG",
"consumption",
"in",
"this",
"study",
"was",
"88",
"kg/km",
"(",
"47.5",
"kg/Nm",
")",
"and",
"diesel",
"consumption",
"was",
"1.3",
"kg/km",
"(",
"0.7",
"kg/Nm",
")",
",",
"allowing",
"for",
"all",
"uses",
"of",
"gas",
"and",
"diesel",
"."
]
}
] |
PMC11406030 | A negative peptide was also chosen from the peptide microarray and ordered with a sequence of rGQSHAPNVNPrDaG. All the peptides were of >95% purity and underwent quality control at Watson Bio. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"negative",
"peptide",
"was",
"also",
"chosen",
"from",
"the",
"peptide",
"microarray",
"and",
"ordered",
"with",
"a",
"sequence",
"of",
"rGQSHAPNVNPrDaG.",
"All",
"the",
"peptides",
"were",
"of",
">",
"95",
"%",
"purity",
"and",
"underwent",
"quality",
"control",
"at",
"Watson",
"Bio",
"."
]
}
] |
PMC11506670 | Cell counts were conducted over three consecutive days. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Cell",
"counts",
"were",
"conducted",
"over",
"three",
"consecutive",
"days",
"."
]
}
] |
PMC11747467 | After exposure to RC48 (HT1376 and SW780), the proteins ERBB2, STAT3, and pSTAT3 (Tyr705) were detected by Western blot analysis. ( | [
{
"tags": [
"O",
"O",
"O",
"B-CellLine",
"O",
"B-CellLine",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"After",
"exposure",
"to",
"RC48",
"(",
"HT1376",
"and",
"SW780",
")",
",",
"the",
"proteins",
"ERBB2",
",",
"STAT3",
",",
"and",
"pSTAT3",
"(",
"Tyr705",
")",
"were",
"detected",
"by",
"Western",
"blot",
"analysis",
".",
"("
]
}
] |
PMC9429973 | Median OS was 28 months (95% CI:18-38) for patients in the UHR group vs. 69 months (95% CI: 61-77) for others (p<0.001). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Median",
"OS",
"was",
"28",
"months",
"(",
"95",
"%",
"CI:18",
"-",
"38",
")",
"for",
"patients",
"in",
"the",
"UHR",
"group",
"vs.",
"69",
"months",
"(",
"95",
"%",
"CI",
":",
"61",
"-",
"77",
")",
"for",
"others",
"(",
"p<0.001",
")",
"."
]
}
] |
PMC10033453 | Oncolytic virotherapy has recently emerged as a promising approach and offers an opportunity for synergistic combinations with other established cancer therapies such as radiation and immune checkpoint inhibitors. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Oncolytic",
"virotherapy",
"has",
"recently",
"emerged",
"as",
"a",
"promising",
"approach",
"and",
"offers",
"an",
"opportunity",
"for",
"synergistic",
"combinations",
"with",
"other",
"established",
"cancer",
"therapies",
"such",
"as",
"radiation",
"and",
"immune",
"checkpoint",
"inhibitors",
"."
]
}
] |
PMC11802855 | B, C Enrichment analysis of KEGG pathways for differentially expressed genes in the CXCL7-OE and NC RPMI8226 cell lines. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O"
],
"tokens": [
"B",
",",
"C",
"Enrichment",
"analysis",
"of",
"KEGG",
"pathways",
"for",
"differentially",
"expressed",
"genes",
"in",
"the",
"CXCL7-OE",
"and",
"NC",
"RPMI8226",
"cell",
"lines",
"."
]
}
] |
PMC9429973 | 45% of patients had any grade AEs. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"45",
"%",
"of",
"patients",
"had",
"any",
"grade",
"AEs",
"."
]
}
] |
PMC6160470 | The exceptions to the “rule” are DACs with the shortest side chain (DAC-1 and −1Amide). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"exceptions",
"to",
"the",
"“",
"rule",
"”",
"are",
"DACs",
"with",
"the",
"shortest",
"side",
"chain",
"(",
"DAC-1",
"and",
"−1Amide",
")",
"."
]
}
] |
PMC11727145 | Notably, DED can be stored at 4 °C for up to five years (Figure 2D) without affecting recellularization, thus allowing for the preparation of large tissue lots that may be banked with uniformity. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Notably",
",",
"DED",
"can",
"be",
"stored",
"at",
"4",
"°",
"C",
"for",
"up",
"to",
"five",
"years",
"(",
"Figure",
"2D",
")",
"without",
"affecting",
"recellularization",
",",
"thus",
"allowing",
"for",
"the",
"preparation",
"of",
"large",
"tissue",
"lots",
"that",
"may",
"be",
"banked",
"with",
"uniformity",
"."
]
}
] |
PMC6461034 | ATCC: American Type Culture Collection The patient‐derived xenograft tumor tissue used in this study was derived from xenograft models that have been described before (Bertotti et al, 2015). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"ATCC",
":",
"American",
"Type",
"Culture",
"Collection",
"The",
"patient‐derived",
"xenograft",
"tumor",
"tissue",
"used",
"in",
"this",
"study",
"was",
"derived",
"from",
"xenograft",
"models",
"that",
"have",
"been",
"described",
"before",
"(",
"Bertotti",
"et",
"al",
",",
"2015",
")",
"."
]
}
] |
PMC9096373 | A study on the use of camptothecin derivative (TLC388) on H23 human non-small cell lung cancer cells revealed that the combination therapy of TLC388 and RT significantly increased γ-H2AX foci percentage (65.4% vs. 26.1%) compared with that using RT alone (22). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"study",
"on",
"the",
"use",
"of",
"camptothecin",
"derivative",
"(",
"TLC388",
")",
"on",
"H23",
"human",
"non-small",
"cell",
"lung",
"cancer",
"cells",
"revealed",
"that",
"the",
"combination",
"therapy",
"of",
"TLC388",
"and",
"RT",
"significantly",
"increased",
"γ-H2AX",
"foci",
"percentage",
"(",
"65.4",
"%",
"vs.",
"26.1",
"%",
")",
"compared",
"with",
"that",
"using",
"RT",
"alone",
"(",
"22",
")",
"."
]
}
] |
PMC9429973 | One year following Temferon, with no 2nd line therapy added, there was approximately 40% reduction in enhancing tumor volume compared to D+180. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"One",
"year",
"following",
"Temferon",
",",
"with",
"no",
"2nd",
"line",
"therapy",
"added",
",",
"there",
"was",
"approximately",
"40",
"%",
"reduction",
"in",
"enhancing",
"tumor",
"volume",
"compared",
"to",
"D+180",
"."
]
}
] |
PMC9599726 | We next investigated lipid peroxidation, the main hallmark of ferroptosis by flow cytometry using C11-BODIPY 581/591. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"next",
"investigated",
"lipid",
"peroxidation",
",",
"the",
"main",
"hallmark",
"of",
"ferroptosis",
"by",
"flow",
"cytometry",
"using",
"C11-BODIPY",
"581/591",
"."
]
}
] |
PMC10900886 | Whether EV-D68 utilizes one dissemination route or more to invade the CNS needs to be investigated further. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Whether",
"EV-D68",
"utilizes",
"one",
"dissemination",
"route",
"or",
"more",
"to",
"invade",
"the",
"CNS",
"needs",
"to",
"be",
"investigated",
"further",
"."
]
}
] |
PMC10631132 | Gene expression of POU5F1 decreased in all groups significantly from the mesodermal to the hematopoietic stage (A). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Gene",
"expression",
"of",
"POU5F1",
"decreased",
"in",
"all",
"groups",
"significantly",
"from",
"the",
"mesodermal",
"to",
"the",
"hematopoietic",
"stage",
"(",
"A",
")",
"."
]
}
] |
PMC11755519 | In addition, the expression of p-AKT and p-STAT3 was higher in exosome-treated macrophages than in untreated macrophages. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"addition",
",",
"the",
"expression",
"of",
"p-AKT",
"and",
"p-STAT3",
"was",
"higher",
"in",
"exosome-treated",
"macrophages",
"than",
"in",
"untreated",
"macrophages",
"."
]
}
] |
PMC6617630 | Data represent mean ± SD from three independent experiments. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Data",
"represent",
"mean",
"±",
"SD",
"from",
"three",
"independent",
"experiments",
"."
]
}
] |
PMC11295144 | To test if NL2 can bind directly to the large intracellular domain of the γ2 subunit, GST-tagged ICL was expressed and purified from E. coli and incubated with the lysates of HEK293 cells transfected with HA-NL2. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"test",
"if",
"NL2",
"can",
"bind",
"directly",
"to",
"the",
"large",
"intracellular",
"domain",
"of",
"the",
"γ2",
"subunit",
",",
"GST-tagged",
"ICL",
"was",
"expressed",
"and",
"purified",
"from",
"E.",
"coli",
"and",
"incubated",
"with",
"the",
"lysates",
"of",
"HEK293",
"cells",
"transfected",
"with",
"HA-NL2",
"."
]
}
] |
PMC5854676 | In these samples, the scale bar was set to 100 nm, and a nanorod morphology of 12 nm diameter and about 80 nm length is shown in Fig. 3(a). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"these",
"samples",
",",
"the",
"scale",
"bar",
"was",
"set",
"to",
"100",
"nm",
",",
"and",
"a",
"nanorod",
"morphology",
"of",
"12",
"nm",
"diameter",
"and",
"about",
"80",
"nm",
"length",
"is",
"shown",
"in",
"Fig.",
"3(a",
")",
"."
]
}
] |
PMC11607321 | Future efforts should leverage multi-omic resources from cancer patients and derived models, such as organoids and patient derived xenografts (PDXs), to enhance training and explore transfer learning opportunities. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Future",
"efforts",
"should",
"leverage",
"multi-omic",
"resources",
"from",
"cancer",
"patients",
"and",
"derived",
"models",
",",
"such",
"as",
"organoids",
"and",
"patient",
"derived",
"xenografts",
"(",
"PDXs",
")",
",",
"to",
"enhance",
"training",
"and",
"explore",
"transfer",
"learning",
"opportunities",
"."
]
}
] |
PMC9429973 | Summary/Conclusion: Our report suggests that CH may be seen as a biological link at the crossroads of IBDs and HMs, whose role is yet to be fully elucidated. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Summary/Conclusion",
":",
"Our",
"report",
"suggests",
"that",
"CH",
"may",
"be",
"seen",
"as",
"a",
"biological",
"link",
"at",
"the",
"crossroads",
"of",
"IBDs",
"and",
"HMs",
",",
"whose",
"role",
"is",
"yet",
"to",
"be",
"fully",
"elucidated",
"."
]
}
] |
PMC11787651 | EpiConverter is available on GitHub at github.com/ChenfengZhao/EpiConverter. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"EpiConverter",
"is",
"available",
"on",
"GitHub",
"at",
"github.com/ChenfengZhao/EpiConverter",
"."
]
}
] |
PMC10759659 | In gastric cancer, ARID1A deficiency was correlated with dMMR and increased expression of PD-L1 . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"gastric",
"cancer",
",",
"ARID1A",
"deficiency",
"was",
"correlated",
"with",
"dMMR",
"and",
"increased",
"expression",
"of",
"PD-L1",
"."
]
}
] |
PMC11401350 | The two lentiviral vector constructs incorporated into these LVs are presented. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"two",
"lentiviral",
"vector",
"constructs",
"incorporated",
"into",
"these",
"LVs",
"are",
"presented",
"."
]
}
] |
PMC7433824 | Twenty mM P4 (Sigma‐P8783) was prepared as stock solutions dissolved in ethanol and sterile medium. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Twenty",
"mM",
"P4",
"(",
"Sigma‐P8783",
")",
"was",
"prepared",
"as",
"stock",
"solutions",
"dissolved",
"in",
"ethanol",
"and",
"sterile",
"medium",
"."
]
}
] |
PMC10291556 | The scratched areas were shot immediately after the complex addition and then after 24 h with a Canon EOS 1200D camera attached to an Olympus CKX41 inverted microscope with a 10×/0.25 phase contrast objective. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"scratched",
"areas",
"were",
"shot",
"immediately",
"after",
"the",
"complex",
"addition",
"and",
"then",
"after",
"24",
"h",
"with",
"a",
"Canon",
"EOS",
"1200D",
"camera",
"attached",
"to",
"an",
"Olympus",
"CKX41",
"inverted",
"microscope",
"with",
"a",
"10",
"×",
"/0.25",
"phase",
"contrast",
"objective",
"."
]
}
] |
PMC11535726 | In addition, most new species in China and Thailand were primarily found in tropical and subtropical regions, with nearly all species growing on decayed wood (Bao et al. 2018; Rodríguez-Andrade et al. 2020; Sun et al. 2021; Jayawardena et al. 2022; Senanayake et al. 2023; Liu et al. 2023b; Yang et al. 2023; de Farias et al. 2024; Louangphan et al. 2024). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"addition",
",",
"most",
"new",
"species",
"in",
"China",
"and",
"Thailand",
"were",
"primarily",
"found",
"in",
"tropical",
"and",
"subtropical",
"regions",
",",
"with",
"nearly",
"all",
"species",
"growing",
"on",
"decayed",
"wood",
"(",
"Bao",
"et",
"al.",
"2018",
";",
"Rodríguez-Andrade",
"et",
"al.",
"2020",
";",
"Sun",
"et",
"al.",
"2021",
";",
"Jayawardena",
"et",
"al.",
"2022",
";",
"Senanayake",
"et",
"al.",
"2023",
";",
"Liu",
"et",
"al.",
"2023b",
";",
"Yang",
"et",
"al.",
"2023",
";",
"de",
"Farias",
"et",
"al.",
"2024",
";",
"Louangphan",
"et",
"al.",
"2024",
")",
"."
]
}
] |
PMC11703992 | Therefore, CD4+ T cells are not only one of the significant key cell clusters that trigger inflammatory responses, but also the important regulators of immune cell populations in GCA development. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Therefore",
",",
"CD4",
"+",
"T",
"cells",
"are",
"not",
"only",
"one",
"of",
"the",
"significant",
"key",
"cell",
"clusters",
"that",
"trigger",
"inflammatory",
"responses",
",",
"but",
"also",
"the",
"important",
"regulators",
"of",
"immune",
"cell",
"populations",
"in",
"GCA",
"development",
"."
]
}
] |
PMC11745823 | A range of microRNAs has been reported to regulate HIF1. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"range",
"of",
"microRNAs",
"has",
"been",
"reported",
"to",
"regulate",
"HIF1",
"."
]
}
] |
PMC11696576 | CCRF-CEM cells seeded at 200,000 viable cells/mL were treated with AVX420 (0.5 μM) or DMSO (0.1%) and harvested after 1 hour, 6 h, or 16 h. Torin-1 (100 nM) treatment was harvested after 1 h. The flasks were placed on ice and the cell suspensions were transferred to 50 mL conical tubes for centrifugation (405 × g, 4 °C, 5 min). | [
{
"tags": [
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"CCRF-CEM",
"cells",
"seeded",
"at",
"200,000",
"viable",
"cells/mL",
"were",
"treated",
"with",
"AVX420",
"(",
"0.5",
"μM",
")",
"or",
"DMSO",
"(",
"0.1",
"%",
")",
"and",
"harvested",
"after",
"1",
"hour",
",",
"6",
"h",
",",
"or",
"16",
"h.",
"Torin-1",
"(",
"100",
"nM",
")",
"treatment",
"was",
"harvested",
"after",
"1",
"h.",
"The",
"flasks",
"were",
"placed",
"on",
"ice",
"and",
"the",
"cell",
"suspensions",
"were",
"transferred",
"to",
"50",
"mL",
"conical",
"tubes",
"for",
"centrifugation",
"(",
"405",
"×",
"g",
",",
"4",
"°",
"C",
",",
"5",
"min",
")",
"."
]
}
] |
PMC11732523 | Laboratory examination of the patient. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Laboratory",
"examination",
"of",
"the",
"patient",
"."
]
}
] |
PMC8345486 | In A2780cis, as in A2780, the compound accumulation (1.49–8.21 nmol) was distinctly above the cisplatin amount (0.75 ± 0.044 nmol, data not shown). | [
{
"tags": [
"O",
"B-CellLine",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"A2780cis",
",",
"as",
"in",
"A2780",
",",
"the",
"compound",
"accumulation",
"(",
"1.49–8.21",
"nmol",
")",
"was",
"distinctly",
"above",
"the",
"cisplatin",
"amount",
"(",
"0.75",
"±",
"0.044",
"nmol",
",",
"data",
"not",
"shown",
")",
"."
]
}
] |
PMC11585994 | This molecule can be taken up by cancer cells and subsequently release the small molecule nucleic acids within the acidic intracellular environment caused by heightened metabolic activity, making it a promising mediator for small molecule nucleic acid delivery.26–31 However, the delivery efficiency and inherent toxicity of PAMAM have limited its direct therapeutic application. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"molecule",
"can",
"be",
"taken",
"up",
"by",
"cancer",
"cells",
"and",
"subsequently",
"release",
"the",
"small",
"molecule",
"nucleic",
"acids",
"within",
"the",
"acidic",
"intracellular",
"environment",
"caused",
"by",
"heightened",
"metabolic",
"activity",
",",
"making",
"it",
"a",
"promising",
"mediator",
"for",
"small",
"molecule",
"nucleic",
"acid",
"delivery.26–31",
"However",
",",
"the",
"delivery",
"efficiency",
"and",
"inherent",
"toxicity",
"of",
"PAMAM",
"have",
"limited",
"its",
"direct",
"therapeutic",
"application",
"."
]
}
] |
PMC9429973 | Than, we compared patients according to the conditioning regimen and the previous treatment. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Than",
",",
"we",
"compared",
"patients",
"according",
"to",
"the",
"conditioning",
"regimen",
"and",
"the",
"previous",
"treatment",
"."
]
}
] |
PMC11538390 | A quantile-quantile plot is shown in the inset panel, where the observed ( y axis) negative log10 P values are plotted against the expected (x axis) negative log10 P values under null distribution (red line). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"quantile-quantile",
"plot",
"is",
"shown",
"in",
"the",
"inset",
"panel",
",",
"where",
"the",
"observed",
"(",
"y",
"axis",
")",
"negative",
"log10",
"P",
"values",
"are",
"plotted",
"against",
"the",
"expected",
"(",
"x",
"axis",
")",
"negative",
"log10",
"P",
"values",
"under",
"null",
"distribution",
"(",
"red",
"line",
")",
"."
]
}
] |
PMC6461034 | in a final round (e.g., round 4) completely distribute the contents of the “stock” vial, emptying it. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"in",
"a",
"final",
"round",
"(",
"e.g.",
",",
"round",
"4",
")",
"completely",
"distribute",
"the",
"contents",
"of",
"the",
"“",
"stock",
"”",
"vial",
",",
"emptying",
"it",
"."
]
}
] |
PMC9024365 | Graph depicts the mean cluster size of M1-3, S2, M4, CT chimera stratified for either co-localized or not co-localized with SD4. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Graph",
"depicts",
"the",
"mean",
"cluster",
"size",
"of",
"M1",
"-",
"3",
",",
"S2",
",",
"M4",
",",
"CT",
"chimera",
"stratified",
"for",
"either",
"co-localized",
"or",
"not",
"co-localized",
"with",
"SD4",
"."
]
}
] |
PMC11676674 | Regarding the assessment of C. monspeliensis genotoxic and antigenotoxic potential, in our work, a pipeline for automated micronuclei analysis using CellProfiler software (version number 4.2.6) with a fluorescence microscope, together with the application of new features and masks developed in the IDEAS software (version number 6.2) of the ImagestreamX imaging flow cytometer for scoring micronuclei in binucleated cells, was developed. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Regarding",
"the",
"assessment",
"of",
"C.",
"monspeliensis",
"genotoxic",
"and",
"antigenotoxic",
"potential",
",",
"in",
"our",
"work",
",",
"a",
"pipeline",
"for",
"automated",
"micronuclei",
"analysis",
"using",
"CellProfiler",
"software",
"(",
"version",
"number",
"4.2.6",
")",
"with",
"a",
"fluorescence",
"microscope",
",",
"together",
"with",
"the",
"application",
"of",
"new",
"features",
"and",
"masks",
"developed",
"in",
"the",
"IDEAS",
"software",
"(",
"version",
"number",
"6.2",
")",
"of",
"the",
"ImagestreamX",
"imaging",
"flow",
"cytometer",
"for",
"scoring",
"micronuclei",
"in",
"binucleated",
"cells",
",",
"was",
"developed",
"."
]
}
] |
PMC11713609 | On the other hand, p53 inhibits VKORC1L1 to restrain the content of reduced vitamin K, a newly identified type of radical-trapping antioxidant, to promote ferroptosis (Yang et al., 2023). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"On",
"the",
"other",
"hand",
",",
"p53",
"inhibits",
"VKORC1L1",
"to",
"restrain",
"the",
"content",
"of",
"reduced",
"vitamin",
"K",
",",
"a",
"newly",
"identified",
"type",
"of",
"radical-trapping",
"antioxidant",
",",
"to",
"promote",
"ferroptosis",
"(",
"Yang",
"et",
"al.",
",",
"2023",
")",
"."
]
}
] |
PMC11792888 | p < 0.05 compared to control (the culture media in absence of scorpion venom) from Kruskal-Wallis non-parametric test. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"p",
"<",
"0.05",
"compared",
"to",
"control",
"(",
"the",
"culture",
"media",
"in",
"absence",
"of",
"scorpion",
"venom",
")",
"from",
"Kruskal-Wallis",
"non-parametric",
"test",
"."
]
}
] |
PMC11344246 | RT-qPCR quantification of siRNA treatment showed equivalent relative knockdown (>80%), which may be why these cell lines showed similar growth inhibition by this method (Supplementary Figure S2). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"RT-qPCR",
"quantification",
"of",
"siRNA",
"treatment",
"showed",
"equivalent",
"relative",
"knockdown",
"(",
">",
"80",
"%",
")",
",",
"which",
"may",
"be",
"why",
"these",
"cell",
"lines",
"showed",
"similar",
"growth",
"inhibition",
"by",
"this",
"method",
"(",
"Supplementary",
"Figure",
"S2",
")",
"."
]
}
] |
PMC11704135 | The desired compounds were created by treating 4,6-dimethylpyrimidine-2-thiol hydrochloride (1) with derivatives of benzoyl chloride and/or sulfonyl chloride, followed by oxidizing the products with glacial acetic acid and hydrogen peroxide. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"desired",
"compounds",
"were",
"created",
"by",
"treating",
"4,6-dimethylpyrimidine-2-thiol",
"hydrochloride",
"(",
"1",
")",
"with",
"derivatives",
"of",
"benzoyl",
"chloride",
"and/or",
"sulfonyl",
"chloride",
",",
"followed",
"by",
"oxidizing",
"the",
"products",
"with",
"glacial",
"acetic",
"acid",
"and",
"hydrogen",
"peroxide",
"."
]
}
] |
PMC10329237 | After 0 and 48 hr, an inverted microscope was utilized to capture images from five independent, random microscopic fields (20). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"After",
"0",
"and",
"48",
"hr",
",",
"an",
"inverted",
"microscope",
"was",
"utilized",
"to",
"capture",
"images",
"from",
"five",
"independent",
",",
"random",
"microscopic",
"fields",
"(",
"20",
")",
"."
]
}
] |
PMC9429973 | POD24 was detected in 38 patients, and its impact on OS was not statistically significant (HR 8.1, p=0.070). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"POD24",
"was",
"detected",
"in",
"38",
"patients",
",",
"and",
"its",
"impact",
"on",
"OS",
"was",
"not",
"statistically",
"significant",
"(",
"HR",
"8.1",
",",
"p=0.070",
")",
"."
]
}
] |
PMC9429973 | Generic molecule would potentially reduces the cost with probable similar outcomes. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Generic",
"molecule",
"would",
"potentially",
"reduces",
"the",
"cost",
"with",
"probable",
"similar",
"outcomes",
"."
]
}
] |
PMC11539788 | The precipitates were detected by western blotting. ( | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"precipitates",
"were",
"detected",
"by",
"western",
"blotting",
".",
"("
]
}
] |
PMC11753949 | Moreover, 65% (± 15%) of them were at contacts between ER vesicles consistent with their role in crosslinking ER cisterns before the hypotonic lysis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Moreover",
",",
"65",
"%",
"(",
"±",
"15",
"%",
")",
"of",
"them",
"were",
"at",
"contacts",
"between",
"ER",
"vesicles",
"consistent",
"with",
"their",
"role",
"in",
"crosslinking",
"ER",
"cisterns",
"before",
"the",
"hypotonic",
"lysis",
"."
]
}
] |
PMC10197932 | The results suggest that some lymphocytes maybe could have some fine mechanisms that control apoptotic events in different extents and ways, such as different expression patterns of anti-apoptotic proteins like Bcl-2 family or maybe downregulation of PUMA or NOXA, pro-apoptotic proteins, or P53 17,34,35, or maybe upregulating UCP2 (uncoupling protein 2) 31,41 which in turn lowers the levels of mitochondrial ROS, or maybe in the regulation of ERK1/2 pathways 42. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"results",
"suggest",
"that",
"some",
"lymphocytes",
"maybe",
"could",
"have",
"some",
"fine",
"mechanisms",
"that",
"control",
"apoptotic",
"events",
"in",
"different",
"extents",
"and",
"ways",
",",
"such",
"as",
"different",
"expression",
"patterns",
"of",
"anti-apoptotic",
"proteins",
"like",
"Bcl-2",
"family",
"or",
"maybe",
"downregulation",
"of",
"PUMA",
"or",
"NOXA",
",",
"pro-apoptotic",
"proteins",
",",
"or",
"P53",
"17,34,35",
",",
"or",
"maybe",
"upregulating",
"UCP2",
"(",
"uncoupling",
"protein",
"2",
")",
"31,41",
"which",
"in",
"turn",
"lowers",
"the",
"levels",
"of",
"mitochondrial",
"ROS",
",",
"or",
"maybe",
"in",
"the",
"regulation",
"of",
"ERK1/2",
"pathways",
"42",
"."
]
}
] |
PMC11653552 | Patients with MM often present with various clinical manifestations including anemia, hypercalcemia, renal impairment, compromised immune function, and particularly osteolytic bone lesions that leads to an increased risk of fractures, contributing to heightened morbidity and mortality . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Patients",
"with",
"MM",
"often",
"present",
"with",
"various",
"clinical",
"manifestations",
"including",
"anemia",
",",
"hypercalcemia",
",",
"renal",
"impairment",
",",
"compromised",
"immune",
"function",
",",
"and",
"particularly",
"osteolytic",
"bone",
"lesions",
"that",
"leads",
"to",
"an",
"increased",
"risk",
"of",
"fractures",
",",
"contributing",
"to",
"heightened",
"morbidity",
"and",
"mortality",
"."
]
}
] |
PMC9621239 | After culturing stable HCC cell lines for 24 h, total RNA was isolated from them using EasyPure RNA Kit (ER101, Transgen, China). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"After",
"culturing",
"stable",
"HCC",
"cell",
"lines",
"for",
"24",
"h",
",",
"total",
"RNA",
"was",
"isolated",
"from",
"them",
"using",
"EasyPure",
"RNA",
"Kit",
"(",
"ER101",
",",
"Transgen",
",",
"China",
")",
"."
]
}
] |
PMC11585565 | The results are from four independent experiments (n = 4). ( | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"results",
"are",
"from",
"four",
"independent",
"experiments",
"(",
"n",
"=",
"4",
")",
".",
"("
]
}
] |
PMC9429973 | However, none of the patients had documented discussion of pain control education, any psychological support they may need nor were encouraged to use their own coping mechanisms for dealing with acute pain in their hospital notes. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"none",
"of",
"the",
"patients",
"had",
"documented",
"discussion",
"of",
"pain",
"control",
"education",
",",
"any",
"psychological",
"support",
"they",
"may",
"need",
"nor",
"were",
"encouraged",
"to",
"use",
"their",
"own",
"coping",
"mechanisms",
"for",
"dealing",
"with",
"acute",
"pain",
"in",
"their",
"hospital",
"notes",
"."
]
}
] |
PMC10006224 | This is one representative experiment of at least 3 performed. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"is",
"one",
"representative",
"experiment",
"of",
"at",
"least",
"3",
"performed",
"."
]
}
] |
PMC11632064 | Strikingly, the responses to BI-D1870 and LJH685 appeared to be compound- and cell line-specific (Fig 1D). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Strikingly",
",",
"the",
"responses",
"to",
"BI-D1870",
"and",
"LJH685",
"appeared",
"to",
"be",
"compound-",
"and",
"cell",
"line-specific",
"(",
"Fig",
"1D",
")",
"."
]
}
] |
PMC11283030 | Flow cytometry (FCM) revealed that ACLY specific siRNA caused an increase in apoptotic rate of 786-O and A498 cells as compared to siRNA-NC at 24 h (P < 0.05; Fig. 4d), suggesting ACLY knockdown could induce ccRCC cell apoptosis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Flow",
"cytometry",
"(",
"FCM",
")",
"revealed",
"that",
"ACLY",
"specific",
"siRNA",
"caused",
"an",
"increase",
"in",
"apoptotic",
"rate",
"of",
"786-O",
"and",
"A498",
"cells",
"as",
"compared",
"to",
"siRNA-NC",
"at",
"24",
"h",
"(",
"P",
"<",
"0.05",
";",
"Fig.",
"4d",
")",
",",
"suggesting",
"ACLY",
"knockdown",
"could",
"induce",
"ccRCC",
"cell",
"apoptosis",
"."
]
}
] |
PMC9429973 | In addition, luciferase was recombinantly expressed in all PDX models to allow repetitive monitoring of leukemia growth and treatment response using bioluminescence in vivo imaging (BLI). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"addition",
",",
"luciferase",
"was",
"recombinantly",
"expressed",
"in",
"all",
"PDX",
"models",
"to",
"allow",
"repetitive",
"monitoring",
"of",
"leukemia",
"growth",
"and",
"treatment",
"response",
"using",
"bioluminescence",
"in",
"vivo",
"imaging",
"(",
"BLI",
")",
"."
]
}
] |
PMC11730320 | F High levels of ICOS-1 expression by CD4+ memory T cells. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"F",
"High",
"levels",
"of",
"ICOS-1",
"expression",
"by",
"CD4",
"+",
"memory",
"T",
"cells",
"."
]
}
] |
PMC11541241 | Jiao et al. (2023) identified the conserved TOR signalling pathway in S. sclerotiorum. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Jiao",
"et",
"al.",
"(",
"2023",
")",
"identified",
"the",
"conserved",
"TOR",
"signalling",
"pathway",
"in",
"S.",
"sclerotiorum",
"."
]
}
] |
PMC9429973 | Modeled variables included clinical, laboratory, demographic, and pharmacological data. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Modeled",
"variables",
"included",
"clinical",
",",
"laboratory",
",",
"demographic",
",",
"and",
"pharmacological",
"data",
"."
]
}
] |
PMC9250505 | Along with Olaparib, Rucaparib and Talazoparib were also approved for the treatment of ovarian cancer regardless of BRCA-mutational status. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Along",
"with",
"Olaparib",
",",
"Rucaparib",
"and",
"Talazoparib",
"were",
"also",
"approved",
"for",
"the",
"treatment",
"of",
"ovarian",
"cancer",
"regardless",
"of",
"BRCA-mutational",
"status",
"."
]
}
] |
PMC3915447 | Our data showed that the expression of antiapoptotic genes such as bcl-2, survivin of CCRF CEM cells were significantly down-regulated after co-treatment of FA with SPIO, whereas the expression of bax was up-regulated. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"I-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Our",
"data",
"showed",
"that",
"the",
"expression",
"of",
"antiapoptotic",
"genes",
"such",
"as",
"bcl-2",
",",
"survivin",
"of",
"CCRF",
"CEM",
"cells",
"were",
"significantly",
"down-regulated",
"after",
"co-treatment",
"of",
"FA",
"with",
"SPIO",
",",
"whereas",
"the",
"expression",
"of",
"bax",
"was",
"up-regulated",
"."
]
}
] |
PMC11026382 | The reads passing these quality control criteria were compared against the wild-type reference sequence to determine mutation identify. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"reads",
"passing",
"these",
"quality",
"control",
"criteria",
"were",
"compared",
"against",
"the",
"wild-type",
"reference",
"sequence",
"to",
"determine",
"mutation",
"identify",
"."
]
}
] |
PMC11786767 | To generate the Ki67-miR knockdown constructs, an artificial miRNA was designed using BLOCK-iT™ RNAi Designer (https://rnaidesigner.thermofisher.com/rnaiexpress/). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"generate",
"the",
"Ki67-miR",
"knockdown",
"constructs",
",",
"an",
"artificial",
"miRNA",
"was",
"designed",
"using",
"BLOCK-iT",
"™",
"RNAi",
"Designer",
"(",
"https://rnaidesigner.thermofisher.com/rnaiexpress/",
")",
"."
]
}
] |
PMC11569208 | For miRNA qPCR, the universal poly-A tail (Agilent) was used as the reverse primer. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"miRNA",
"qPCR",
",",
"the",
"universal",
"poly-A",
"tail",
"(",
"Agilent",
")",
"was",
"used",
"as",
"the",
"reverse",
"primer",
"."
]
}
] |
PMC7192625 | Moreover, we confirmed an association of chromatin marks to chromatin structure that leads to preferential contacts between chromatin regions with similar chromatin (47). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Moreover",
",",
"we",
"confirmed",
"an",
"association",
"of",
"chromatin",
"marks",
"to",
"chromatin",
"structure",
"that",
"leads",
"to",
"preferential",
"contacts",
"between",
"chromatin",
"regions",
"with",
"similar",
"chromatin",
"(",
"47",
")",
"."
]
}
] |
PMC11714165 | The NBD‐T demonstrated a modest anti‐cancer activity (Figure 3G). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"NBD‐T",
"demonstrated",
"a",
"modest",
"anti‐cancer",
"activity",
"(",
"Figure",
"3",
"G",
")",
"."
]
}
] |
PMC11684269 | In line with previous studies, this process is independent of mTOR and AMPK (110). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"line",
"with",
"previous",
"studies",
",",
"this",
"process",
"is",
"independent",
"of",
"mTOR",
"and",
"AMPK",
"(",
"110",
")",
"."
]
}
] |
PMC10955424 | The Adenomatous Polyposis Coli (APC)/ catenin/TCF pathway, that regulates cell division, angiogenesis, and apoptosis, is a significant depiction of such a system . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"Adenomatous",
"Polyposis",
"Coli",
"(APC)/",
"catenin/TCF",
"pathway",
",",
"that",
"regulates",
"cell",
"division",
",",
"angiogenesis",
",",
"and",
"apoptosis",
",",
"is",
"a",
"significant",
"depiction",
"of",
"such",
"a",
"system",
"."
]
}
] |
PMC11143482 | All parameters measured presented as mean ± SD obtained from three independent experiments where each procedure was performed in triplicates. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"All",
"parameters",
"measured",
"presented",
"as",
"mean",
"±",
"SD",
"obtained",
"from",
"three",
"independent",
"experiments",
"where",
"each",
"procedure",
"was",
"performed",
"in",
"triplicates",
"."
]
}
] |
PMC11377827 | The reactions were washed three times in 1xPBS, lysed with 50 µl 2 x SDS and analysed by immunoblotting. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"reactions",
"were",
"washed",
"three",
"times",
"in",
"1xPBS",
",",
"lysed",
"with",
"50",
"µl",
"2",
"x",
"SDS",
"and",
"analysed",
"by",
"immunoblotting",
"."
]
}
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.